- Home
- ANIX vs SRL Comparison
ANIX vs SRL Comparison
Compare ANIX & SRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANIX
- SRL
- Stock Information
- Founded
- ANIX 1982
- SRL 2017
- Country
- ANIX United States
- SRL China
- Employees
- ANIX N/A
- SRL N/A
- Industry
- ANIX Biotechnology: Pharmaceutical Preparations
- SRL Professional Services
- Sector
- ANIX Health Care
- SRL Consumer Discretionary
- Exchange
- ANIX Nasdaq
- SRL Nasdaq
- Market Cap
- ANIX 101.4M
- SRL 121.2M
- IPO Year
- ANIX 1987
- SRL N/A
- Fundamental
- Price
- ANIX $3.08
- SRL $7.92
- Analyst Decision
- ANIX Strong Buy
- SRL
- Analyst Count
- ANIX 2
- SRL 0
- Target Price
- ANIX $8.50
- SRL N/A
- AVG Volume (30 Days)
- ANIX 128.3K
- SRL 7.9K
- Earning Date
- ANIX 01-14-2025
- SRL 12-09-2024
- Dividend Yield
- ANIX N/A
- SRL N/A
- EPS Growth
- ANIX N/A
- SRL N/A
- EPS
- ANIX N/A
- SRL 0.07
- Revenue
- ANIX N/A
- SRL $41,604,386.00
- Revenue This Year
- ANIX N/A
- SRL N/A
- Revenue Next Year
- ANIX N/A
- SRL N/A
- P/E Ratio
- ANIX N/A
- SRL $116.22
- Revenue Growth
- ANIX N/A
- SRL N/A
- 52 Week Low
- ANIX $2.15
- SRL $4.09
- 52 Week High
- ANIX $5.13
- SRL $8.59
- Technical
- Relative Strength Index (RSI)
- ANIX 42.34
- SRL 48.91
- Support Level
- ANIX $3.07
- SRL $7.65
- Resistance Level
- ANIX $4.20
- SRL $7.93
- Average True Range (ATR)
- ANIX 0.30
- SRL 0.27
- MACD
- ANIX -0.06
- SRL -0.01
- Stochastic Oscillator
- ANIX 2.61
- SRL 51.92
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc, a cancer-focused biotechnology company, developing vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.
About SRL Scully Royalty Ltd.
Scully Royalty Ltd is a royalty-based company that maximizes earnings upon its iron ore royalty interest. The company's business segments include Royalty, which includes an interest in an iron ore mine; Industrial, which includes projects in resources and services; Merchant Banking, which comprises regulated merchant banking activities; and others. The majority of the revenue is generated from the Royalty segment. The company's geographical segments include Canada, Africa, America, Asia, and Europe, out of which Canada accounts for the majority of the revenue.